The Oncogenic Human Papillomavirus Involvement as a Risk Factor of Measles, Mumps, and Rubella Vaccine Immunotherapy Failure in Anogenital Warts
Pati Aji Achdiat,1 Dyah Ismiranty,1 Reti Hindritiani,1 Trustia Rizqandaru,1 Hermin Aminah Usman,2 Retno Hesty Maharani1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, Indonesia; 2Department of Anatomical Pathology, Facu...
Saved in:
| Main Authors: | Achdiat PA, Ismiranty D, Hindritiani R, Rizqandaru T, Usman HA, Maharani RH |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | International Medical Case Reports Journal |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-oncogenic-human-papillomavirus-involvement-as-a-risk-factor-of-mea-peer-reviewed-fulltext-article-IMCRJ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful Treatment with a Combination of Oral and Topical Glycyrrhizinic Acid in an Immunocompetent Anogenital Warts Patient
by: Achdiat PA, et al.
Published: (2025-05-01) -
Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
by: Hui Xu, et al.
Published: (2019-01-01) -
A Randomised Single-Blind Controlled Trial Comparing Efficacy of Intralesional Vitamin D Injection and MMR (Measles, Mumps, Rubella) Vaccine in Treatment of Warts
by: Sushil Singh, et al.
Published: (2025-05-01) -
The Effectiveness of Genital Wart Treatments
by: Dilek Bıyık Özkaya, et al.
Published: (2023-09-01) -
Tissue expression of hsa-microRNA-3654 in male patients with external anogenital warts
by: Mohamed A.I. Elsayed, et al.
Published: (2025-05-01)